RP Bio lnc (XKRX:314140) Change In Receivables : ₩6,491 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Change In Receivables?

RP Bio lnc's change in receivables for the quarter that ended in Jun. 2024 was ₩2,426 Mil. It means RP Bio lnc's Accounts Receivable declined by ₩2,426 Mil from Mar. 2024 to Jun. 2024 .

RP Bio lnc's change in receivables for the fiscal year that ended in Dec. 2023 was ₩753 Mil. It means RP Bio lnc's Accounts Receivable declined by ₩753 Mil from Dec. 2022 to Dec. 2023 .

RP Bio lnc's Accounts Receivable for the quarter that ended in Jun. 2024 was ₩16,946 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. RP Bio lnc's Days Sales Outstanding for the three months ended in Jun. 2024 was 48.20.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. RP Bio lnc's liquidation value for the three months ended in Jun. 2024 was ₩-15,833 Mil.

RP Bio lnc Change In Receivables Historical Data

The historical data trend for RP Bio lnc's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Change In Receivables Chart

RP Bio lnc Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

2,792.33

-5,225.28

-4,395.79

-1,875.92

752.79

RP Bio lnc Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Change In Receivables	Get a 7-Day Free Trial							-972.12	-1,396.74	4,499.49	961.82	2,426.42

RP Bio lnc Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,491 Mil.

RP Bio lnc (XKRX:314140) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

RP Bio lnc's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	16945.883	/	32079.042	*	91
=	48.20

2. In Ben Graham's calculation of liquidation value, RP Bio lnc's accounts receivable are only considered to be worth 75% of book value:

RP Bio lnc's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	16548.362	-	58336.809	+	0.75 * 16945.883	+	0.5 * 26492.65
=	-15,833

RP Bio lnc Change In Receivables Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

RP Bio lnc Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084

Website

http://www.rpskorea.com

RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc Headlines

No Headlines